CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO & President gave up 29,415 shares (to pay taxes)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Financial Officer acquired 17,242 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO & President bought 1,930 shares at an average $8.81 ($16,995)
- 4 Option exercise Chief Financial Officer acquired 7,598 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,273 shares (to pay taxes)
- 4 Open-market sale Director sold 24,777 shares at an average $10.07 ($249,603)
- 4 Open-market sale Director sold 45,531 shares at an average $10.12 ($460,750)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 13 · 251 filings